ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | +1100.0% | 58,436 | +982.1% | 0.00% | – |
| Q2 2022 | $1,000 | – | 5,400 | +1250.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 400 | -99.4% | 0.00% | – |
| Q4 2021 | $40,000 | – | 71,752 | +23817.3% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 300 | -99.2% | 0.00% | – |
| Q2 2021 | $54,000 | -16.9% | 39,588 | +3.7% | 0.00% | – |
| Q1 2021 | $65,000 | +30.0% | 38,179 | -6.1% | 0.00% | – |
| Q4 2020 | $50,000 | +11.1% | 40,645 | +26.3% | 0.00% | – |
| Q3 2020 | $45,000 | -2.2% | 32,171 | -14.0% | 0.00% | – |
| Q2 2020 | $46,000 | -37.0% | 37,387 | -39.2% | 0.00% | – |
| Q1 2020 | $73,000 | -72.7% | 61,448 | -51.5% | 0.00% | – |
| Q4 2019 | $267,000 | +51.7% | 126,760 | +58.8% | 0.00% | – |
| Q3 2019 | $176,000 | +41.9% | 79,810 | +63.8% | 0.00% | – |
| Q2 2019 | $124,000 | -19.5% | 48,710 | +9.7% | 0.00% | – |
| Q1 2019 | $154,000 | +8.5% | 44,419 | -27.9% | 0.00% | – |
| Q4 2018 | $142,000 | +468.0% | 61,619 | +860.8% | 0.00% | – |
| Q3 2018 | $25,000 | +733.3% | 6,413 | +541.3% | 0.00% | – |
| Q2 2018 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -60.0% | 1,000 | -59.3% | 0.00% | – |
| Q4 2017 | $5,000 | 0.0% | 2,456 | +145.6% | 0.00% | – |
| Q3 2017 | $5,000 | -66.7% | 1,000 | -86.2% | 0.00% | – |
| Q2 2017 | $15,000 | +50.0% | 7,261 | +121.8% | 0.00% | – |
| Q1 2017 | $10,000 | -41.2% | 3,273 | -50.1% | 0.00% | – |
| Q4 2016 | $17,000 | -15.0% | 6,559 | +31.0% | 0.00% | – |
| Q3 2016 | $20,000 | +400.0% | 5,005 | +252.2% | 0.00% | – |
| Q2 2016 | $4,000 | -98.2% | 1,421 | -98.0% | 0.00% | – |
| Q1 2016 | $217,000 | +1872.7% | 70,602 | +2465.5% | 0.00% | – |
| Q4 2015 | $11,000 | +266.7% | 2,752 | +175.2% | 0.00% | – |
| Q3 2015 | $3,000 | -88.0% | 1,000 | -83.3% | 0.00% | – |
| Q2 2015 | $25,000 | -88.9% | 6,000 | -89.7% | 0.00% | – |
| Q1 2015 | $226,000 | +334.6% | 58,500 | +654.0% | 0.00% | – |
| Q4 2014 | $52,000 | – | 7,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |